Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo

• Status: Recruiting
• Trial end date: 2022-12-30
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this clinical trial is to assess the efficacy and safety of a combination of aminobutyric acid, glutamic acid, calcium, thiamine, pyridoxine and cyanocobalamin as adjuvant therapy for vertigo comparatively to ginger under a double-blind randomized study design.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Fundação Educacional Serra dos Órgãos
• Treatments: gamma-Aminobutyric Acid; Hydroxocobalamin; Pyridoxine; Thiamine; Vitamin B 12

Criteria

Inclusion Criteria:

• clinical kinetosis

• female study subjects must agree in using contraceptives during study period

• dated informed consent read, understood and undersigned

Exclusion Criteria:

• hypersensitivity to the drugs of the study

• history of gallblader stones

• history of gastric mucosa inflammation

• arterial blood pressure >145/100 mmHg

• use of medication for kinetosis other than the study drugs